J. Hadjadj Et Al. , "Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study," RHEUMATOLOGY , vol.62, pp.341-346, 2022
Hadjadj, J. Et Al. 2022. Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study. RHEUMATOLOGY , vol.62 , 341-346.
Hadjadj, J., Canzian, A., KARADAĞ, Ö., Contis, A., Maurier, F., Sanges, S., ... Sartorelli, S.(2022). Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study. RHEUMATOLOGY , vol.62, 341-346.
Hadjadj, Jerome Et Al. "Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study," RHEUMATOLOGY , vol.62, 341-346, 2022
Hadjadj, Jerome Et Al. "Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study." RHEUMATOLOGY , vol.62, pp.341-346, 2022
Hadjadj, J. Et Al. (2022) . "Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study." RHEUMATOLOGY , vol.62, pp.341-346.
@article{article, author={Jerome Hadjadj Et Al. }, title={Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study}, journal={RHEUMATOLOGY}, year=2022, pages={341-346} }